CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $36,000 | +12.5% | 11,424 | +3.0% | 0.00% | – |
| Q4 2021 | $32,000 | -27.3% | 11,087 | 0.0% | 0.00% | – |
| Q3 2021 | $44,000 | -95.6% | 11,087 | -86.7% | 0.00% | – |
| Q1 2021 | $1,011,000 | +18.1% | 83,259 | +41.9% | 0.00% | – |
| Q4 2020 | $856,000 | +90.6% | 58,666 | +50.3% | 0.00% | – |
| Q3 2020 | $449,000 | – | 39,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 0 | $0 | 0.00% |